Methods: A total of 84 patients with elastofibroma dorsi (12 males, 72 females; mean age: 55.5±7.0 years; range, 43 to 74 years) were retrospectively analyzed between April 2007 and May 2019. Dominant hand, location, size, sex, age, occupations and follow-up of the mass were recorded and the pre- and postoperative Visual Analog Scale scores were noted.
Results: The mean symptom duration was 9.5±7.8 (range, 3 to 48) months. The lesions were located on the right in 49 (58.3%), on the left in 16 (19%) and bilateral in 19 (22.6%). There was no significant difference between the mass size and age, symptom duration and complication development (p=0.129). A significant relation was found between the formation of the mass on the side of the dominant hand (p=0.010). A significant difference was found between the pre- and postoperative Day 90 Visual Analog Scale scores (p<0.001), indicating a significant decrease in the pain scores.
Conclusion: Elastofibroma dorsi has good clinical results after surgical resection. In our series, the patients had significantly more elastofibroma dorsi on their dominant-hand side.
Elastofibroma dorsi consists of microscopically proliferated tumor cells of fibroblasts and accumulated abnormal elastic fibers. It is assumed that connective tissue degeneration is caused by repeated friction of the chest wall and tip of scapula, due to the use of the extremity.[1] Therefore, it has usually been found in patients who frequently repeat occupational handwork. In the English literature, there is no clinical trial showing the exact relationship between recurrent mechanical trauma and ELD.
In this study, we aimed to investigate the correlation between the side of ELD formation and the dominanthand of the patients we operated.
Surgical technique
All patients were operated under general anesthesia,
in the posterolateral thoracotomy position, and patients
with bilateral ELD in two sequential sessions with an
interval of three weeks (Figure 1c). First, the latissimus
dorsi muscle was separated by a transverse incision,
then the solid-irregular shaped lesion attached to
serratus anterior muscle and the periosteum of the ribs
was excised totally. After careful bleeding control, a
small drain was placed in the lobe and it was terminated
when t he d rainage w as ≤25 m L/day. C ompressed
dressings were used up to three days postoperatively to
prevent possible seroma and hematoma complications. Histopathological examinations were completed and
confirmed by three pathologists.
Statistical analysis
Statistical analysis was performed using the IBM
SPSS for Windows version 22.0 software (IBM Corp.,
Armonk, NY, USA). Descriptive data were expressed
in mean ± standard deviation (SD), median (min-max)
or number and frequency, where applicable. The
relationship between grouped variables was tested
using the chi-square test. Repeated measurements
and the difference between two independent groups
were analyzed by paired group t-test, and Pearson
correlation was used to identify differences between
continuous variables. A p v alue o f < 0.05 w as
considered statistically significant.
Table 1: Patient characteristics
All patients presented with pain accompanying a mass, and it could be clearly seen with the abduction and elevation of the arm on dorso (Figure 1a). The diagnosis was confirmed by MRI in all patients. The mean duration of symptoms before applying to our clinic was 9.5±7.8 (range, 3 to 48) months. The mean macroscopic dimension of the resected mass was 77.6±29.8 mm (range, 50 to 130) mm (Figure 1d). Pathological examination revealed elastic and collagen fibers accompanying mature adipose tissue for all patients, consistent with ELD diagnosis (Figure 2).
Figure 2: Microscopic views of the specimen (H&E, x40).
The mean follow-up was 32.5±20.1 (range, 4 to 120) months. Complications developed in 15 (17.9%) patients. In 12 patients who developed seroma, cure was achieved with simple aspiration and pressed dressing, while three patients with hematoma were spontaneously resorbed with pressed dressings. No significant difference was found between patient age or lesion size and the complication development (p=0.124). During follow-up, no recurrence nor new onset contralateral ELD occurrence was observed.
Comparison of VAS scores at postoperative Day 0 (VAS0) and Day 90 (VAS90) scores showed that patients' pain complaints decreased significantly in the postoperative period (p<0.001).
The operated patients had 49 (58.3%) right-sided, 16 (22.6%) left-sided, and 19 (22.6%) bilaterally located lesions. A significant relation was found with the side of mass and the dominant hand (p=0.010) (Table 2). In addition, ELD was detected under the right scapula in 45 (66.2%) patients. In six (37.5%) of the patients using the left hand, the mass was observed on the left. When the statistical relationship between the side of the mass with larger size and the dominant hand was examined in patients with bilateral ELD, there was a significant relationship in the left-hand dominant group (p=0.003), whereas the right-handed ones were not significant (p>0.05).
Table 2: Relationship between elastofibroma dorsi formation and dominant-hand side
In addition to this mechanical theory, there are studies in the literature containing two controversial evidences supporting genetic predisposition theory.[14,17] In the largest series in literature of 170 cases, about 38% reported familiar predisposition (not a specific study of genetic status).[14] The second genetic theory is that it occurs due to varying degrees of gene's hypo- or hyper-expression on different chromosomes.[18,19] Some authors have also explained the formation of ELD due to vascular insufficiency and relative ischemia in the scapular area. This pathogenesis theory has not been extensively addressed and has only been reported as a reference hypothesis so far.[20] Considering the characteristic features of ELD, it is evidence supporting that it is caused by mechanical repetitive micro injuries rather than genetic predisposition, rather than being seen more frequently in individuals over the age of 50 years.[21,22] In our cohort, we did not encounter any patient with a family medical history with previous ELD, in contrast with this theory for our study.
Although ELD is known to be a very rare benign soft tissue tumor, its actual incidence may be higher. The CT examinations taken in the normal population reveal an ELD incidence of 2%.[3] In autopsy series, ELD was observed in 11.2% in males and 24.4% in females over 55 years old.[4] In our series, the number of women (85.7%) with ELD was higher than men; mostly were reported to be housewives (66.6%, n=56). The incidence of bilateral EDL was reported to be between 12 and 73%,[3,5] and it was 22.6% in our series.
Pain and mass formation in the subscapular region are the most common symptoms. In the series of 76 cases, pain (93%), functional restriction (51.3%), and mass appearance during abduction of the arm (31%) were the commonest complaints of patients with ELD.[6] In our series, there were pain complaints in all 84 cases, and in 52 (61.9%) cases, there was also a mass that accompanied the pain (Table 1). A similar literature study reported that the VAS score of the patients decreased from 4.6 to 2.4 at 4.6 years of follow-up.[7] When we compared the pre- and postoperative VAS scores, we observed that pain decreased after the removal of the mass significantly (p<0.001).
Due to common clinical symptoms, ELD can get misdiagnoses such as rotator cuff syndrome or cervical vertebrae problems. Some cases may not be diagnosed, unless they are over 5 cm in CT or MRI.[8]
Magnetic resonance imaging is the best tool to confirm the diagnosis (Figure 1b). We observed that patients who did not complain of mass, but just with back pain complaints were evaluated by orthopedics and physical rehabilitation clinics many times beforehand and could not be diagnosed correctly for a long time. Fibrous tissue shows a low signal intensity in the T1 and T2 sequences, while fat tissue shows high signal intensity in the T1 sequence. Adipose tissue appears as lines in fibrous tissue parallel to the chest wall.[9] It is used in characteristic cases as a diagnostic method in ultrasound (US).[10] In studies using positron emission tomography (PET)/CT, the mean standard uptake value (SUV) of 18F-fluorodeoxyglucose has been shown to be 2.29.[11] Blumenkrantz et al.[12] reported that PET/CT detected ELD in 1.66% of patients. Only two of our patients had PET/CT scans taken simultaneously for other reasons. The SUV of these patients were 2.35 and 1.99, respectively. Since no malignant transformation of ELD, except for only one case, was reported of high spindle cell sarcoma and ELD together in the current literature,[13] we did not perform biopsy in any patient preoperatively.
None of the patients we operated in our series had a family history. The mean age of the patients was 55.5±7.0 years. In this study, no significant relationship was found between mass size and age (p=0.124). Although indications for surgery are still controversial, resection is usually recommended in symptomatic cases over 5 cm. Some authors argue that surgical resection is necessary for pathological confirmation, whether symptomatic or not.[23,24] All of the patients in this series were patients who presented with pain complaints, and we found that, particularly after the surgery, pain decreased and daily activities increased, significantly.
Recurrence rates between 0.06 and 4.5% are reported in the literature.[14,25] In our series, we performed a surgical re-resection due to recurrence in a patient operated by a general surgeon 15 years ago. No ipsilateral- or contralateral-occurrence/recurrence was seen in any patients during our mean duration of 32.5±20.1 months, postoperatively.
The most frequently reported complications after ELD resection are hematoma and seroma formation, as high as 40 to 50%, directly proportional with increasing tumor size.[14,26,27] There is no consensus on postoperative rehabilitation, but one week of immobilization is recommended.[26] We did not restrict any patient"s mobilization, but we applied compression dressing, to prevent early postoperative hematoma formation, and resulted in 18% incidence of hematoma or seroma within the first 30 days. In patients who developed seroma after discharge, we achieved treatment with needle aspiration and pressurized dressing.
The main limitations of this study are its single-center and retrospective design. However, comparatively high cohort volume and long follow-up duration features were the main strengths. To the best of our knowledge, our study is the first study to reveal the relationship between the dominant hand used and the development of the tumor, and is also the second largest series in the English literature,[14] as well as the largest case series in the thoracic surgery literature, proving the benefits of surgical treatment for patients suffering severe pain.
In conclusion, elastofibroma dorsi, which is a rare, slow growing soft tissue tumor located in the subacapular region, has good clinical results after surgical resection. In our series, the patients had significantly more elastofibroma dorsi on their dominant-hand side. However, we believe that it is appropriate to examine larger case series to reveal the definitive etiological relationship.
Ethics Committee Approval: The study protocol was approved by the Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital Ethics Committee (Date/no: 06.05.2021/116.2017.R-219). The study was conducted in accordance with the principles of the Declaration of Helsinki.
Patient Consent for Publication: A written informed consent was obtained from each patient.
Data Sharing Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.
Author Contributions: Conception - S.K.M.; Design - S.E.; Data collection and processing - S.K.M., S.E.; Analysis and interpretion - S.K.M., S.E.; Final approval - S.K.M., S.E.
Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.
Funding: The authors received no financial support for the research and/or authorship of this article.
1) Jarvi O, Saxen E. Elastofibroma dorse. Acta Pathol Microbiol
Scand Suppl 1961;51(Suppl 144):83-4.
2) Giebel GD, Bierhoff E, Vogel J. Elastofibroma and preelastofibroma--
a biopsy and autopsy study. Eur J Surg Oncol
1996;22:93-6.
3) Brandser EA, Goree JC, El-Khoury GY. Elastofibroma dorsi:
Prevalence in an elderly patient population as revealed by
CT. AJR Am J Roentgenol 1998;171:977-80.
4) Järvi OH, Länsimies PH. Subclinical elastofibromas in the
scapular region in an autopsy series. Acta Pathol Microbiol
Scand A 1975;83:87-108.
5) Pilge H, Hesper T, Holzapfel BM, Prodinger PM, Straub M,
Krauspe R. Elastofibroma: Clinical results after resection of
a rare tumor entity. Orthop Rev (Pavia) 2014;6:5329.
6) El Hammoumi M, Qtaibi A, Arsalane A, El Oueriachi
F, Kabiri el H. Elastofibroma dorsi: Clinicopathological
analysis of 76 cases. Korean J Thorac Cardiovasc Surg
2014;47:111-6.
7) Parratt MT, Donaldson JR, Flanagan AM, Saifuddin
A, Pollock RC, Skinner JA, et al. Elastofibroma dorsi:
Management, outcome and review of the literature. J Bone
Joint Surg [Br] 2010;92:262-6.
8) Deveci MA, Özbarlas HS, Erdoğan KE, Biçer ÖS, Tekin M,
Özkan C. Elastofibroma dorsi: Clinical evaluation of 61 cases
and review of the literature. Acta Orthop Traumatol Turc
2017;51:7-11.
9) Malghem J, Baudrez V, Lecouvet F, Lebon C, Maldague
B, Vande Berg B. Imaging study findings in elastofibroma
dorsi. Joint Bone Spine 2004;71:536-41.
10) Haykir R, Karakose S, Karabacakoglu A. Elastofibroma
dorsi: Typical radiological features. Australas Radiol
2007;51:95-7.
11) Fang N, Wang YL, Zeng L, Wu ZJ, Cui XJ, Wang Q, et al.
Characteristics of elastofibroma dorsi on PET/CT imaging
with (18)F-FDG. Clin Imaging 2016;40:110-3.
12) Blumenkrantz Y, Bruno GL, González CJ, Namías M,
Osorio AR, Parma P. Characterization of elastofibroma dorsi
with (18)FDG PET/CT: A retrospective study. Rev Esp Med
Nucl 2011;30:342-5.
13) Alberghini M, Bacchini P, Pignatti G, Maltarello MC, Zanella
L, Maraldi NM, et al. Histochemical and ultrastructural
study of an elastofibroma dorsi coexisting with a high grade
spindle cell sarcoma. Eur J Histochem 2004;48:173-8.
14) Nagamine N, Nohara Y, Ito E. Elastofibroma in
Okinawa. A clinicopathologic study of 170 cases. Cancer
1982;50:1794-805.
15) Muratori F, Esposito M, Rosa F, Liuzza F, Magarelli N, Rossi
B, et al. Elastofibroma dorsi: 8 case reports and a literature
review. J Orthop Traumatol 2008;9:33-7.
16) Elalmiş DD, Tan U. Hand preference in Turkish population.
Int J Neurosci 2005;115:705-12.
17) Lococo F, Cesario A, Mattei F, Petrone G, Vita LM, Petracca-
Ciavarella L, et al. Elastofibroma dorsi: clinicopathological
analysis of 71 cases. Thorac Cardiovasc Surg 2013;61:215-22.
18) Yu JS, Weis LD, Vaughan LM, Resnick D. MRI of
elastofibroma dorsi. J Comput Assist Tomogr 1995;19:601-3.
19) Nishida A, Uetani M, Okimoto T, Hayashi K, Hirano T.
Bilateral elastofibroma of the thighs with concomitant
subscapular lesions. Skeletal Radiol 2003;32:116-8.
20) Stemmermann GN, Stout AP. Elastofibroma dorsi. Am J Clin
Pathol 1962;37:499-506.
21) Chandrasekar CR, Grimer RJ, Carter SR, Tillman RM, Abudu
A, Davies AM, et al. Elastofibroma dorsi: An uncommon
benign pseudotumour. Sarcoma 2008;2008:756565.
22) Freixinet J, Rodríguez P, Hussein M, Sanromán B, Herrero J,
Gil R. Elastofibroma of the thoracic wall. Interact Cardiovasc
Thorac Surg 2008;7:626-8.
23) Pierce JC 3rd, Henderson R. Hypermetabolism of
elastofibroma dorsi on PET-CT. AJR Am J Roentgenol
2004;183:35-7.
24) Ochsner JE, Sewall SA, Brooks GN, Agni R. Best cases
from the AFIP: Elastofibroma dorsi. Radiographics
2006;26:1873-6.
25) Lococo F, Cesario A, Mattei F, Petrone G, Vita LM,
Petracca-Ciavarella L, et al. Elastofibroma dorsi:
Clinicopathological analysis of 71 cases. Thorac
Cardiovasc Surg 2013;61:215-22.